Michael Lauseker

5.0k citations
69 papers · 1.1k · h-index 18

Impact in

  • Hematology top 2%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 2%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 26
    • Acute Myeloid Leukemia Research 21
    • Chronic Lymphocytic Leukemia Research 20
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 7

Michael Lauseker

64 papers receiving 1.1k citations

Peers

Michael Lauseker
Comparison fields: 5 of 86
  • Hematology 618
  • Genetics 429
  • Internal Medicine 94
  • Rheumatology 214
  • Oncology 170
Replace Toshihiko Imamura with:
Toshihiko Imamura Japan
Pravin Hissaria Australia
F. Ross United States
Marrie C.A. Bruin Netherlands
Aiko Suminoe Japan
S Fukuhara Japan
Shahram Kordasti United Kingdom
Ralf Ulrich Trappe Germany
C. Larroche France
Andrew Daly Canada
Michael Lauseker relative to Toshihiko Imamura Japan Toshihiko Imamura's profile →
Citations per field
00.5×8.5×
Toshihiko Imamura · 1×
Citations per year

Countries citing papers authored by Michael Lauseker

Since Specialization
Citations

This map shows the geographic impact of Michael Lauseker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lauseker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lauseker more than expected).

Fields of papers citing papers by Michael Lauseker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lauseker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lauseker. The network helps show where Michael Lauseker may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Lauseker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Lauseker Line = papers co-authored together Michael Lauseker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011218
2 2009112
3 201858
4 201854
5 201252
6 201346
7 201943
8 201234
9 201133
10 201329
11 201728
12 201322
13 201419
14 201819
15 201419
16 201419
17 201718
18 201718
19 202317
20 201717

About Michael Lauseker

Michael Lauseker is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Neurology, having authored 69 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (26 papers), Acute Myeloid Leukemia Research (21 papers), Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (10 papers), Acute Lymphoblastic Leukemia research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Epilepsy research and treatment (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Hematology (618 citations), Genetics (429 citations), Internal Medicine (94 citations), Rheumatology (214 citations) and Oncology (170 citations). Michael Lauseker has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Joerg Hasford, Rüdiger Hehlmann, Markus Pfirrmann, Susanne Saußele, Andreas Hochhaus, C. Hamel-Desnos, M. Schadeck, François‐André Allaert, Rainer Haas and Ulrich Germing. Their work appears in journals such as Blood, Leukemia, Leukemia Research, Annals of Hematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact